Aripiprazole Treatment of the Prodrome

Stopped early · Not applicable

Conditions studied: Prodromal Schizophrenia, Prodromal Psychosis

In brief

The RAP Program is conducting a research study of the antipsychotic medication Aripiprazole. This drug has been approved for treating symptoms associated with schizophrenia and is associated with fewer side effects. This study will explore how well Aripiprazole treats symptoms of early-onset psychotic disorders as well as symptoms that may indicate risk for such disorders, including unusual thoughts, suspiciousness, perceptual abnormalities, social isolation, and sudden changes in functioning.

Key facts

Study ID

NCT00169949

Run by

Northwell Health

People needed

30

Starts

2004-01-01

Expected to finish

2006-05-01

Last updated by the study team

2009-09-25

Who can join

Age: 13 and older, up to 22. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• You are between the ages of 13 and 22.
• You are English-speaking.
• You have a diagnosed psychotic disorder, including: schizophrenia, schizophreniform disorder, schizoaffective disorder, or other psychotic disorder
• OR -
• You are experiencing one or more pre-psychotic symptoms like unusual thoughts, suspiciousness, or unusual perceptual experiences.
• You meet additional RAP criteria assessed during screening and interview.

You may not qualify if…

• You have a diagnosis of bipolar disorder or major depression with psychotic features.
• You have a history of neurological, neuroendocrine, or other medical conditions known to affect the brain.
• You have past or current substance dependence.
• You are currently taking Aripiprazole.
• You have taken Aripiprazole in the past.
• You are currently taking and responding well to another medication.

Where it is running

• RAP Program, Dept. of Psychiatry Research, The Zucker Hillside Hospital — Glen Oaks, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.